Location History:
- Kanagawa, JP (2012 - 2013)
- Yokohama, JP (2013)
Company Filing History:
3 out of 47 
2 out of 2,405 
Years Active: 2012-2013
Title: Yu Onozaki: Innovator in Cancer Treatment
Introduction
Yu Onozaki is a notable inventor based in Kanagawa, Japan, recognized for his contributions to the field of cancer treatment through innovative compounds. With a total of three patents to his name, Onozaki has made significant strides in the development of inhibitors targeting Akt activity, which plays a crucial role in cancer progression.
Latest Patents
Onozaki's latest patents include groundbreaking inventions that focus on inhibiting Akt activity. The first patent describes substituted fused naphthyridine derivatives that selectively inhibit one or two of the Akt isoforms. This invention also outlines compositions that comprise these inhibitory compounds and methods for administering them to patients in need of cancer treatment. The second patent presents substituted [1,2,4]triazolo[4,3-a]-1,5-naphthyridine compounds, which similarly inhibit Akt activity, particularly Akt1. This patent also details compositions and methods for treating cancer by administering these compounds to patients.
Career Highlights
Throughout his career, Yu Onozaki has worked with prominent companies in the pharmaceutical industry, including MSD K.K. and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in developing innovative solutions for cancer treatment.
Collaborations
Onozaki has collaborated with esteemed colleagues such as Nobuhiko Kawanishi and
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.